About Chris Ballas
Chris brings over 25 years of experience working on cell and gene therapies with expertise in research, development, testing, and manufacturing of viral vectors and cell therapies. Currently, he is the SVP of Manufacturing for Innovative Cellular Therapeutics, where he specializes in autologous ex vivo lentiviral vector stem cell and CAR-T cell therapies.
Chris has served in consulting/senior and executive roles for multiple gene therapy companies and recently co-developed an ultra-high throughput microinjection device and co-founded Basilard Biotech in order to commercialize this technology. He holds a PhD in Cellular and Molecular Pathology from Vanderbilt University School of Medicine and was a Children’s Brittle Bone Foundation fellow during a post-doctoral fellowship at Case Western Reserve University School of Medicine.
Why Genezen? As an Indiana native and former faculty member at the Indiana University School of Medicine, I am excited to see Genezen expand their capabilities in my home state.
I’m passionate about Solving the practical problems and challenges associated with making cell and gene therapies a viable and effective option for patients.
Meet our People
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.